EISAI CO
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public
- Established
- 1941-12-06
- Employees
- 11K
- Market Cap
- $12B
- Website
- http://www.eisai.co.jp
An add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic Drugs (AEDs)
- First Posted Date
- 2009-02-23
- Last Posted Date
- 2013-02-07
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT00849212
E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-01-30
- Last Posted Date
- 2015-04-30
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT00832819
A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-10-10
- Last Posted Date
- 2012-11-22
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 369
- Registration Number
- NCT00770692
Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis
- First Posted Date
- 2008-10-10
- Last Posted Date
- 2012-04-18
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 337
- Registration Number
- NCT00770913
A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-10-10
- Last Posted Date
- 2013-02-04
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 192
- Registration Number
- NCT00770510
A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome
- First Posted Date
- 2008-02-20
- Last Posted Date
- 2013-05-13
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT00619164
A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy Bodies
- First Posted Date
- 2008-01-22
- Last Posted Date
- 2014-09-03
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 160
- Registration Number
- NCT00598650
A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-10-15
- Last Posted Date
- 2013-03-08
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 167
- Registration Number
- NCT00543855
A Double-Blind Study of E5555 in Japanese Subjects With Coronary Artery Disease
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-10-08
- Last Posted Date
- 2013-05-13
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT00540670
A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
- First Posted Date
- 2007-03-08
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 135
- Registration Number
- NCT00445172
© Copyright 2024. All Rights Reserved by MedPath